Peter Ainsworth

8.0k total citations
96 papers, 4.1k citations indexed

About

Peter Ainsworth is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Peter Ainsworth has authored 96 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Genetics, 39 papers in Molecular Biology and 17 papers in Oncology. Recurrent topics in Peter Ainsworth's work include BRCA gene mutations in cancer (35 papers), Ovarian cancer diagnosis and treatment (13 papers) and Epigenetics and DNA Methylation (12 papers). Peter Ainsworth is often cited by papers focused on BRCA gene mutations in cancer (35 papers), Ovarian cancer diagnosis and treatment (13 papers) and Epigenetics and DNA Methylation (12 papers). Peter Ainsworth collaborates with scholars based in Canada, United States and Poland. Peter Ainsworth's co-authors include Steven A. Narod, David I. Rodenhiser, Jan Lubiński, Henry T. Lynch, William D. Foulkes, Charmaine Kim‐Sing, Ping Sun, Parviz Ghadirian, Andrea Eisen and Bekim Sadiković and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Peter Ainsworth

96 papers receiving 4.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Ainsworth Canada 37 2.3k 1.6k 941 821 543 96 4.1k
Ruth Gershoni‐Baruch Israel 39 1.7k 0.8× 3.1k 2.0× 812 0.9× 573 0.7× 374 0.7× 145 6.1k
Hanne Meijers‐Heijboer Netherlands 40 2.5k 1.1× 1.9k 1.2× 1.1k 1.1× 1.1k 1.3× 251 0.5× 98 4.9k
Marc De Braekeleer France 40 1.7k 0.7× 1.9k 1.2× 325 0.3× 287 0.3× 719 1.3× 235 5.6k
Charles H.C.M. Buys Netherlands 42 1.5k 0.7× 3.2k 2.0× 1.8k 1.9× 1.3k 1.6× 181 0.3× 155 7.0k
Thomas van Overeem Hansen Denmark 31 1.2k 0.5× 2.6k 1.7× 613 0.7× 970 1.2× 137 0.3× 136 4.5k
Charles V. Clevenger United States 44 984 0.4× 2.6k 1.6× 1.9k 2.1× 690 0.8× 244 0.4× 102 5.2k
Catherine Bonaïti‐Pellié France 35 2.7k 1.2× 2.1k 1.3× 981 1.0× 538 0.7× 79 0.1× 109 5.4k
Francesca Spinella Italy 40 582 0.3× 2.4k 1.5× 775 0.8× 619 0.8× 441 0.8× 94 4.8k
Norio Wake Japan 40 841 0.4× 1.8k 1.2× 684 0.7× 688 0.8× 425 0.8× 171 4.6k
Philippe Jonveaux France 31 1.6k 0.7× 2.1k 1.3× 511 0.5× 236 0.3× 119 0.2× 134 4.1k

Countries citing papers authored by Peter Ainsworth

Since Specialization
Citations

This map shows the geographic impact of Peter Ainsworth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Ainsworth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Ainsworth more than expected).

Fields of papers citing papers by Peter Ainsworth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Ainsworth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Ainsworth. The network helps show where Peter Ainsworth may publish in the future.

Co-authorship network of co-authors of Peter Ainsworth

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Ainsworth. A scholar is included among the top collaborators of Peter Ainsworth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Ainsworth. Peter Ainsworth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McCuaig, Jeanna, Kathleen Buckley, Kara Semotiuk, et al.. (2021). Incidental findings from cancer next generation sequencing panels. npj Genomic Medicine. 6(1). 63–63. 13 indexed citations
2.
Aref‐Eshghi, Erfan, Danielle K. Bourque, Jennifer Kerkhof, et al.. (2019). Genome‐wide DNA methylation and RNA analyses enable reclassification of two variants of uncertain significance in a patient with clinical Kabuki syndrome. Human Mutation. 40(10). 1684–1689. 19 indexed citations
3.
Metcalfe, Kelly, Andrea Eisen, Leigha Senter, et al.. (2019). International trends in the uptake of cancer risk reduction strategies in women with a BRCA1 or BRCA2 mutation. British Journal of Cancer. 121(1). 15–21. 102 indexed citations
4.
Aref‐Eshghi, Erfan, David I. Rodenhiser, Laila C. Schenkel, et al.. (2018). Genomic DNA Methylation Signatures Enable Concurrent Diagnosis and Clinical Genetic Variant Classification in Neurodevelopmental Syndromes. The American Journal of Human Genetics. 102(1). 156–174. 90 indexed citations
5.
Kotsopoulos, Joanne, Jacek Gronwald, Henry T. Lynch, et al.. (2018). Age at first full-term birth and breast cancer risk in BRCA1 and BRCA2 mutation carriers. Breast Cancer Research and Treatment. 171(2). 421–426. 10 indexed citations
6.
Schenkel, Laila C., Kristin D. Kernohan, Arran McBride, et al.. (2017). Identification of epigenetic signature associated with alpha thalassemia/mental retardation X-linked syndrome. Epigenetics & Chromatin. 10(1). 10–10. 42 indexed citations
7.
Aref‐Eshghi, Erfan, Laila C. Schenkel, Hanxin Lin, et al.. (2017). Clinical Validation of a Genome-Wide DNA Methylation Assay for Molecular Diagnosis of Imprinting Disorders. Journal of Molecular Diagnostics. 19(6). 848–856. 26 indexed citations
8.
Kernohan, Kristin D., Laila C. Schenkel, Lijia Huang, et al.. (2016). Identification of a methylation profile for DNMT1-associated autosomal dominant cerebellar ataxia, deafness, and narcolepsy. Clinical Epigenetics. 8(1). 91–91. 50 indexed citations
9.
Schenkel, Laila C., Jennifer Kerkhof, Alan Stuart, et al.. (2016). Clinical Next-Generation Sequencing Pipeline Outperforms a Combined Approach Using Sanger Sequencing and Multiplex Ligation-Dependent Probe Amplification in Targeted Gene Panel Analysis. Journal of Molecular Diagnostics. 18(5). 657–667. 43 indexed citations
10.
Cybulski, Cezary, Jan Lubiński, Tomasz Huzarski, et al.. (2015). Prospective evaluation of alcohol consumption and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Breast Cancer Research and Treatment. 151(2). 435–441. 8 indexed citations
11.
Semple, John L., Kelly Metcalfe, Henry T. Lynch, et al.. (2013). International Rates of Breast Reconstruction After Prophylactic Mastectomy in BRCA1 and BRCA2 Mutation Carriers. Annals of Surgical Oncology. 20(12). 3817–3822. 23 indexed citations
12.
Metcalfe, Kelly, Jan Lubiński, Henry T. Lynch, et al.. (2010). Family History of Cancer and Cancer Risks in Women with BRCA1 or BRCA2 Mutations. JNCI Journal of the National Cancer Institute. 102(24). 1874–1878. 75 indexed citations
13.
Metcalfe, Kelly, Daphna Birenbaum‐Carmeli, Jan Lubiński, et al.. (2008). International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers. International Journal of Cancer. 122(9). 2017–2022. 261 indexed citations
14.
Metcalfe, Kelly, Parviz Ghadirian, Barry P. Rosen, et al.. (2007). Variation in Rates of Uptake of Preventive Options in BRCA1 and BRCA2 Mutation Carriers Across Canada. 1(2). 92–98. 8 indexed citations
15.
Temple, Claire, Jeremy Parfitt, David T. Shum, et al.. (2007). Clinical significance of the RT‐PCR positive sentinel node in melanoma. Journal of Surgical Oncology. 95(7). 546–554. 6 indexed citations
16.
Kwon, Janice S., John Lenehan, Mark Carey, & Peter Ainsworth. (2007). Prolonged survival among women with BRCA germline mutations and advanced endometrial cancer: a case series. International Journal of Gynecological Cancer. 18(3). 546–549. 11 indexed citations
17.
Kotsopoulos, Joanne, Jan Lubiński, Susan L. Neuhausen, et al.. (2005). Hormone replacement therapy and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers. Gynecologic Oncology. 100(1). 83–88. 32 indexed citations
18.
Jernström, Helena, Jan Lubiński, Henry T. Lynch, et al.. (2004). Breast-feeding and the Risk of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers. JNCI Journal of the National Cancer Institute. 96(14). 1094–1098. 135 indexed citations
19.
Demaerschalk, Bart M., et al.. (2001). A Canadian CADASIL Kindred: How sensitive is a skin biopsy?. Stroke. 32. 331–331. 1 indexed citations
20.
O’Malley, Frances P., Zahida Saad, Nancy Kerkvliet, et al.. (1996). The predictive power of semiquantitative immunohistochemical assessment of p53 and c-erb B-2 in lymph node-negative breast cancer. Human Pathology. 27(9). 955–963. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ruth Gershoni‐Baruch Breakdown of academic impact, for papers by Hanne Meijers‐Heijboer Breakdown of academic impact, for papers by Marc De Braekeleer Breakdown of academic impact, for papers by Charles H.C.M. Buys Breakdown of academic impact, for papers by Thomas van Overeem Hansen Breakdown of academic impact, for papers by Charles V. Clevenger Breakdown of academic impact, for papers by Catherine Bonaïti‐Pellié Breakdown of academic impact, for papers by Francesca Spinella Breakdown of academic impact, for papers by Norio Wake Breakdown of academic impact, for papers by Philippe Jonveaux
Rankless by CCL
2026